SCHEMBL9707782

SCHEMBL9707782

CCCc1nc2c(c(=O)n(CC3CC3)c(=O)n2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.45
AGTR2 P50052 7/20 0.45
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
PDE5A O76074 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707932 0.95 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9707342 0.95 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9708423 0.94 AGTR1 (0.45) AGTR1AGTR2PDE5APDE4APDE4B
SCHEMBL9707589 0.94 AGTR1 (0.45) AGTR1AGTR2ADORA3ADORA2APDE5A
SCHEMBL9707582 0.94 PDE5A (0.48) AGTR1AGTR2ADORA3ADORA2APDE5A
SCHEMBL9708082 0.92 PDE5A (0.47) AGTR1AGTR2ADORA3ADORA2APDE5A
SCHEMBL9707615 0.92 AGTR1 (0.45) AGTR1AGTR2ADORA3ADORA1PDE5A
SCHEMBL9707920 0.90 AGTR1 (0.43) AGTR1AGTR2ADORA3PDE5APDE4A
SCHEMBL9708536 0.90 AGTR1 (0.46) AGTR1AGTR2ALOX15HSD17B10
SCHEMBL9707955 0.90 AGTR1 (0.46) AGTR1AGTR2ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO claimed
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed